Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef
about
HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulsesSoluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2Current Advances in Virus-Like Particles as a Vaccination Approach against HIV InfectionRNA-Based Vaccines in Cancer ImmunotherapyDNA encoding an HIV-1 Gag/human lysosome-associated membrane protein-1 chimera elicits a broad cellular and humoral immune response in Rhesus macaques.Quantitative effect of suboptimal codon usage on translational efficiency of mRNA encoding HIV-1 gag in intact T cells.A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapyDendritic cell-based human immunodeficiency virus vaccine.Polyelectrolyte capsules-containing HIV-1 p24 and poly I:C modulate dendritic cells to stimulate HIV-1-specific immune responses.Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients.Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllersPreclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cellsEfficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individualsImmunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial.Extensive HLA class I allele promiscuity among viral CTL epitopes.Novel strategies for improved cancer vaccines.Evaluation of cellular immune responses in cancer vaccine recipients: lessons from NY-ESO-1.Dendritic cell immunotherapy for HIV infection: from theory to reality.Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system.Lipoplexes carrying mRNA encoding Gag protein modulate dendritic cells to stimulate HIV-specific immune responses.Interleukin-12p70 expression by dendritic cells of HIV-1-infected patients fails to stimulate gag-specific immune responses.In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles.HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells.Aminopeptidase substrate preference affects HIV epitope presentation and predicts immune escape patterns in HIV-infected individuals.High-level antigen expression and sustained antigen presentation in dendritic cells nucleofected with wild-type viral mRNA but not DNA.Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells.
P2860
Q22001527-9F4C22F3-7396-42AA-83EB-ED2400DD7BBDQ24295002-CEF80AF3-02AD-4051-9B68-73077958CA18Q26775082-BA0DFEEB-75FC-49AA-8C70-088AF4AB5D7BQ26776028-0BF4FE53-B65B-4B44-AB96-A4F1F09A6B99Q33268303-D264F688-CC2A-4A92-A4FB-824139231C20Q33340267-60D2693F-B921-464F-85B4-87702CF51506Q33645564-A00A29ED-4A2A-4F19-8B81-D19FCAC7DE6AQ33874652-F7707F90-A56B-4398-A93D-2260B9B58F5DQ34025136-824FE13F-F0B1-4D41-B1A9-154CFE74AA7DQ34080118-F74B1153-648C-4074-AC0A-A68B589EA002Q34120046-325674C0-757E-460D-87D9-FE1ACB68EE5CQ34612545-37A96039-5513-4D6A-AC66-803CCD43F795Q36229149-C438C195-14F3-497C-9132-5EC32A6B4AE4Q36498151-2251D672-6032-4BC8-9CF1-100165DB20E8Q36576603-44A1397A-7876-4FE7-ACAA-BD511F202EF4Q37066721-9127A637-6DAF-4208-A6F1-C77C15B8739DQ37461365-77F81321-8490-42CA-9F5F-7C309037A357Q37762274-EC809011-356F-468C-99AA-0BD5B40B1144Q37773251-3071FF21-F21D-4E60-ACC3-E88D6766A24BQ38031222-817F4852-DF61-4DEF-A736-27E26F7728DFQ38965589-1D87E21A-81DD-46F9-B5EC-90D79A470EDFQ39550595-E6A12F37-95AA-49EB-A230-E2ABA8882768Q39574217-8F22E3C6-3C20-4475-BB2C-0F2CE5EE7A3AQ40706800-E06E0E80-5420-455E-8E25-B315AF9A13F8Q42187290-0E7B49CD-A610-41C4-B9A0-571CD373F539Q42751318-B323ED70-7424-4620-9EF1-168DCCA1DB12Q43196387-B8000F54-43FD-4186-AB57-8B48F10F5F3A
P2860
Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Expansion of HIV-specific CD4+ ...... lasm- or lysosome-targeted Nef
@ast
Expansion of HIV-specific CD4+ ...... lasm- or lysosome-targeted Nef
@en
type
label
Expansion of HIV-specific CD4+ ...... lasm- or lysosome-targeted Nef
@ast
Expansion of HIV-specific CD4+ ...... lasm- or lysosome-targeted Nef
@en
prefLabel
Expansion of HIV-specific CD4+ ...... lasm- or lysosome-targeted Nef
@ast
Expansion of HIV-specific CD4+ ...... lasm- or lysosome-targeted Nef
@en
P2093
P2860
P50
P1433
P1476
Expansion of HIV-specific CD4+ ...... lasm- or lysosome-targeted Nef
@en
P2093
Bradford S Wagner
Daniel E Kaufmann
Daniel G Kavanagh
David Boczkowski
David R Stone
Eli Gilboa
Mary N Johnston
Mohammad T Zaman
Nicole Frahm
Nina Bhardwaj
P2860
P304
P356
10.1182/BLOOD-2005-04-1513
P407
P577
2005-10-25T00:00:00Z